Douglas Grossman, MD, Ph.D., co-leader of the Melanoma Center at Huntsman Cancer Institute at the University of Utah (the U) and professor of dermatology at the U, has helped develop a noninvasive technology that aims to improve melanoma screening outcomes and reduce unnecessary procedures. Grossman and a team evaluated the accuracy of Skin Fluorescent Imaging (SFI), a system developed by Orlucent, Inc. that reads the molecular makeup of moles and lesions without removing possibly cancerous skin.
This article was originally published on MedicalXpress.com
